Lee SM, et al. – Objective of this study was to establish and internally validate a nomogram using biparametric magnetic resonance imaging (B–MRI)–derived variables for the prediction of prostate cancer at transperineal sector–guided prostate biopsy (TPSB). It was considered that these internally validated MR–based nomograms were able to accurately predict TPSB outcomes for prostate cancer, especially significant disease. The outcomes support the combination of prebiopsy MRI results and clinical factors as part of the biopsy decision–making process.